#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Atypical haemolytic uraemic syndrome Oropharyngeal cancer recurrent Acquired C1 inhibitor deficiency Small cell lung cancer limited stage Cytokine release syndrome Glomerulonephritis acute Myotonic dystrophy Hypotransferrinaemia Cardiac sarcoidosis Cardiac arrest Severe myoclonic epilepsy of infancy Oesophageal squamous cell carcinoma stage III Rett syndrome Choroid melanoma Glycogen storage disease type I More trials…

    Learn about Rare Diseases

    Haemophilia B without inhibitors – Life with Disease Anaplastic thyroid cancer – Trials in Disease Basal cell naevus syndrome Antisynthetase syndrome – Treatment Haemophilia A with anti factor VIII – Basic Information Optic glioma – Life with Disease X-linked lymphoproliferative syndrome – Life with Disease Sjogren’s syndrome – Trials in Disease Isodicentric chromosome 15 syndrome – Life with Disease Lymphangioma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tobramycin Lenalidomide Florbetaben (18F) Calcium Folinate Pentahydrate Dabigatran Etexilate ATUMELNANT Fosfomycin Midazolam Hydrochloride Sotalol Hydrochloride Xaluritamig Olopatadine Erythromycin Lactobionate Ursodoxicoltaurine Palivizumab Enoxaparin Sodium Hydroxycarbamide Esomeprazole Magnesium RPTR-1-201 GSKVX000000039711 Elexacaftor More therapies…

    Learn about Your Condition

    Gout Menopausal symptoms Genital herpes Thrombosis Cutaneous T-cell lymphoma Aphthous ulcer Stress Familial mediterranean fever Uveal melanoma Acquired haemophilia Obliterative bronchiolitis Skin candida Pneumonia chlamydial Aneurysm ruptured Immune thrombocytopenia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello…

Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello

Via Trabucco 180, Palermo, 90146, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Quizartinib with Chemotherapy for Adults with Newly Diagnosed FLT3-ITD Negative Acute Myeloid Leukemia

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Cytarabine
    • Daunorubicin Hydrochloride
    • Idarubicin Hydrochloride
    Austria Belgium Bulgaria Croatia Czechia France +9

  • Study of Inotuzumab Ozogamicin and drug combination in adult patients with B-cell Acute Lymphoblastic Leukemia who have minimal residual disease before stem cell transplantation

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Cyclophosphamide
    • Inotuzumab Ozogamicin
    • Mercaptopurine
    Italy

  • Study on the Effects of Zasocitinib for Patients with Moderate to Severe Ulcerative Colitis

    Not recruiting

    2 1
    Investigated Drugs:
    • Zasocitinib
    Belgium Bulgaria Czechia Denmark France Germany +7

  • Study of Pembrolizumab for Patients with Relapsed or Refractory Classical Hodgkin’s Lymphoma or Primary Mediastinal Large B-cell Lymphoma

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Pembrolizumab
    Czechia Italy Poland

  • Study for Adults with Very High-Risk T-Cell Acute Lymphoblastic Leukemia Using Daratumumab and a Drug Combination

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • T-cell type acute leukaemia
    Investigated Drugs:
    • Aciclovir
    • Allopurinol
    • Amphotericin B
    Italy

  • Study on Loncastuximab Tesirine for Patients with Relapsed or Refractory Mantle Cell Lymphoma After Immunochemotherapy with Rituximab, Bendamustine, and Cytarabine

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Mantle cell lymphoma recurrent
    • Mantle cell lymphoma refractory
    Investigated Drugs:
    • Loncastuximab Tesirine
    Italy

  • Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone with Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma Patients Ineligible for Transplant

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Carfilzomib
    • Dexamethasone Sodium Phosphate
    • Lenalidomide
    Italy

  • Study on the Effectiveness and Safety of Mitapivat for Patients with Sickle Cell Disease

    Not recruiting

    4 1
    Investigated Diseases:
    • Anaemia
    Investigated Drugs:
    • Mitapivat
    Belgium France Germany Italy The Netherlands

  • Study Comparing Divarasib, Sotorasib, and Adagrasib for Patients with Advanced or Metastatic KRAS G12C-Positive Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Austria Belgium Denmark Finland France Germany +7

  • Study Comparing AVT16 and Vedolizumab for Adults with Moderate to Severe Ulcerative Colitis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute haemorrhagic ulcerative colitis
    Investigated Drugs:
    • Sodium Chloride
    • Vedolizumab
    Bulgaria Croatia Czechia Greece Hungary Italy +5
Previous Page
1 … 4 5 6 7 8 … 11
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!